Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 3, 2001, Pages 188-193

  Menashe, G ^a   Borer, A ^a   Yagupsky, P ^a   Peled, N ^a   Gilad, J ^a   Fraser, D ^a   Riesenberg, K ^a   Schlaeffer, F ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEZLOCILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CENTRAL VENOUS CATHETERIZATION; CITROBACTER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROBACTER; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; HEART FAILURE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; PROTEUS MIRABILIS; SERRATIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035093724     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540151060806     Document Type: Article

References (27)

1. β-lactamase-mediated resistance and opportunities for its control
2. Antimicrobial resistance with focus on β-lactam resistance in Gram-negative bacilli
3. Detection and clinical significance of extended spectrum β-lactamases in a tertiary-care medical center
4. Clinical significance of extended spectrum beta-lactamases
5. Beta-lactamases: Current situation and clinical importance
6. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
7. Extended-spectrum plasmid mediated β-lactamases
8. Molecular epidemiology of an SHV-5 extended spectrum β-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit
9. Extended spectrum β-lactamases
10. The molecular and clinical epidemiology of Enterobacteriaceae producing extended-spectrum β-lactamase in a tertiary care hospital
11. Antibiotic susceptibility testing by a standardized single disc method
12. Nosocomial bacteremia in critically ill patients: Multicenter study evaluating epidemiology and prognosis
13. CDC definitions for nosocomial infections, 1988
14. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
15. The clinical significance of positive blood cultures in the 1990's: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
16. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase
17. Perspectives of beta-lactamase inhibitors in the therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins
18. Characterization of ceftriaxone-resistant Enterobacteriaceae: A multicenter study in 26 French hospitals
19. Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe
20. More extended-spectrum β-lactamases
21. Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multi-resistant Klebsiella pneumoniae
22. Patterns of multiple resistance to antibiotics in Gram-negative bacteria demonstrated by factor analysis
23. Antimicrobial susceptibility in gram-negative bacteremia: Are nosocomial isolates really more resistant?
24. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition
25. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation
26. Comparative in vitro and in vivo activities of piperacillin combined with the β-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam